Natural products are a diverse class of naturally occurring chemical compounds with a broad spectrum of biological activities. They have long served as a cornerstone of drug discovery, offering unique chemical scaffolds and molecular frameworks that have significantly advanced the development of new therapeutics. Over the past decades, pharmaceutical companies and drug discovery organizations have identified an increasing number of bioactive molecules from natural products. However, for many of these compounds, the precise molecular targets and mechanisms of action remain largely unknown.
A drug target refers to the biomolecule—often a protein—that interacts with a compound to elicit a therapeutic effect. Traditional drug discovery typically followed a "one ingredient, one target, one disease" paradigm. In contrast, many drugs, particularly natural products, act on multiple targets. While this polypharmacology can complicate target identification, it also presents unique opportunities to discover novel targets and gain deeper insights into the multifaceted biological activities of natural products. Identifying the targets of bioactive natural products is therefore crucial for elucidating their mechanisms of action, optimizing therapeutic potential, and accelerating the drug development process. By systematically mapping NP-target interactions, researchers can uncover both primary and secondary targets, predict off-target effects, and inform rational drug design. These insights are especially valuable for compounds with multiple pharmacological effects, enabling a clearer understanding of their biological properties and therapeutic potential.
At our company, our bioactive natural products target identification technology platforms provide an integrated solution for systematically deciphering the interactions between natural products and their biological targets, facilitating more efficient, precise, and reliable drug discovery pipelines.
Explore Our Technology Platform
Our technology platform integrates state-of-the-art methodologies to provide comprehensive target identification for bioactive natural products. We categorize our approaches into two main strategies: Probe-based Approaches and Label-free Approaches.
Probe-based approaches (affinity chromatography, ABPP, PAL, ABPP coupled with SILAC) involve the chemical modification of natural products to create molecular probes that can capture their protein targets, allowing researchers to pinpoint direct interactions and map precise binding sites within proteins.
Label-free approaches (biophysical methods, omics-based approaches, computational prediction) offer a complementary strategy that does not require chemical modification of the natural product, preserving its native bioactivity. They are particularly advantageous for studying compounds with labile structures or when chemical modification might interfere with biological activity.
Our Advantages
- Comprehensive Target Coverage: By integrating both probe-based and label-free approaches, we can identify a broad spectrum of targets, including direct binders, allosteric modulators, and transient interactors.
- Mechanistic Insight: Beyond simple target identification, our platform enables detailed mapping of binding sites, interaction networks, and downstream signaling pathways, providing actionable mechanistic insights.
- Versatility Across Bioactive Compounds: Our platform accommodates a wide range of natural product classes, including alkaloids, terpenoids, polyphenols, and peptides, regardless of chemical complexity or solubility.
- Customizable Workflows: We tailor our experimental design to the specific properties of the compound and the biological context, ensuring robust and reproducible results for each project.
- Expert Interpretation: Our team consists of Ph.D. level scientists who specialize in mass spectrometry data analysis and structural biology.
Our bioactive natural products target identification technology platforms combine cutting-edge chemical biology, omics, and biophysical approaches to empower researchers in discovering novel drug targets, elucidating mechanisms of action, and advancing natural product-based therapeutics. By leveraging both probe-based and label-free methodologies, we deliver accurate, comprehensive, and actionable insights that drive innovation in drug discovery and translational research.
Online Inquiry